Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Umpqua Bank

Umpqua Bank reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 2,942 shares of the medical equipment provider’s stock after selling 174 shares during the period. Umpqua Bank’s holdings in Intuitive Surgical were worth $1,445,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Catalina Capital Group LLC increased its holdings in shares of Intuitive Surgical by 6.6% in the 3rd quarter. Catalina Capital Group LLC now owns 2,668 shares of the medical equipment provider’s stock valued at $1,311,000 after acquiring an additional 166 shares during the period. Avidian Wealth Enterprises LLC grew its position in Intuitive Surgical by 7.0% during the 3rd quarter. Avidian Wealth Enterprises LLC now owns 656 shares of the medical equipment provider’s stock worth $322,000 after purchasing an additional 43 shares during the last quarter. Falcon Wealth Planning grew its holdings in shares of Intuitive Surgical by 0.4% during the third quarter. Falcon Wealth Planning now owns 5,693 shares of the medical equipment provider’s stock worth $2,797,000 after buying an additional 23 shares during the last quarter. Crestwood Advisors Group LLC increased its position in Intuitive Surgical by 3.2% in the 3rd quarter. Crestwood Advisors Group LLC now owns 4,432 shares of the medical equipment provider’s stock valued at $2,177,000 after acquiring an additional 139 shares during the period. Finally, Arthur M. Cohen & Associates LLC raised its stake in Intuitive Surgical by 4.8% during the 3rd quarter. Arthur M. Cohen & Associates LLC now owns 9,818 shares of the medical equipment provider’s stock valued at $4,759,000 after acquiring an additional 446 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded up $2.33 during trading hours on Wednesday, hitting $517.50. 120,985 shares of the company were exchanged, compared to its average volume of 1,449,791. The stock has a market capitalization of $184.32 billion, a price-to-earnings ratio of 82.82, a P/E/G ratio of 4.98 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $269.49 and a one year high of $525.00. The business’s 50-day simple moving average is $491.63 and its two-hundred day simple moving average is $449.59.

Insiders Place Their Bets

In related news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 68,246 shares of company stock valued at $33,839,308 in the last quarter. Insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. Barclays boosted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Finally, Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.